1. Home
  2. INO vs AMTX Comparison

INO vs AMTX Comparison

Compare INO & AMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inovio Pharmaceuticals Inc.

INO

Inovio Pharmaceuticals Inc.

HOLD

Current Price

$2.07

Market Cap

136.6M

Sector

Health Care

ML Signal

HOLD

Logo Aemetis Inc. (DE)

AMTX

Aemetis Inc. (DE)

HOLD

Current Price

$1.47

Market Cap

150.1M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
INO
AMTX
Founded
1979
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
136.6M
150.1M
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
INO
AMTX
Price
$2.07
$1.47
Analyst Decision
Buy
Strong Buy
Analyst Count
5
3
Target Price
$9.00
$17.00
AVG Volume (30 Days)
1.1M
840.1K
Earning Date
11-10-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$182,337.00
$201,323,000.00
Revenue This Year
N/A
$0.66
Revenue Next Year
$21,219.94
$118.86
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.30
$1.22
52 Week High
$4.08
$3.66

Technical Indicators

Market Signals
Indicator
INO
AMTX
Relative Strength Index (RSI) 49.53 34.34
Support Level $1.86 $1.43
Resistance Level $2.27 $1.60
Average True Range (ATR) 0.12 0.11
MACD 0.04 0.01
Stochastic Oscillator 59.72 12.68

Price Performance

Historical Comparison
INO
AMTX

About INO Inovio Pharmaceuticals Inc.

Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

About AMTX Aemetis Inc. (DE)

Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. It owns and operates an approximately 65 million gallon per year ethanol production facility located in Keyes, California. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. It operates in the reportable geographic segments of North America and India.

Share on Social Networks: